Saito, Takefumi <br/><br/>
Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE.  [electronic resource] 

 -  International journal of chronic obstructive pulmonary disease  2015 
 - 2393-404 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1178-2005 
<br/><br/><label>Standard No.: </label>10.2147/COPD.S89948  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Aged<br/>Area Under Curve<br/>Bronchodilator Agents--administration & dosage<br/>Cholinergic Antagonists--administration & dosage<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Fluticasone-Salmeterol Drug Combination--administration & dosage<br/>Forced Expiratory Volume<br/>Humans<br/>Japan<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Nebulizers and Vaporizers<br/>Plethysmography<br/>Predictive Value of Tests<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>ROC Curve<br/>Recovery of Function<br/>Severity of Illness Index<br/>Spirometry<br/>Time Factors<br/>Tiotropium Bromide--administration & dosage<br/>Treatment Outcome<br/>Vital Capacity